A prognostic approach on a case of pediatric Philadelphia chromosome‐positive acute lymphoblastic leukemia with monosomy‐7

In this work, we present the first case of a Ph‐positive ALL Moroccan girl with t(9;22)(q34;q11) and monosomy‐7. She was diagnosed with Ph‐positive ALL based on bone marrow examination, immunophenotyping, and cytogenetic analysis. She relapsed after treatment with the persistence of the Ph chromosome and the appearance of a monosomy‐7.

[1]  D. Steinemann,et al.  Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol , 2020, Genes, chromosomes & cancer.

[2]  M. Weirauch,et al.  The Ikaros1, IKZF1, risk locus for Acute Lymphoblastic Leukemia (ALL) at chromosome 7p12.2 regulates the expression of the FIGNL1 gene , 2020, The Journal of Immunology.

[3]  L. Linares,et al.  Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer , 2019, Molecular metabolism.

[4]  R. Jaksik,et al.  PTEN abnormalities predict poor outcome in children with T‐cell acute lymphoblastic leukemia treated according to ALL IC‐BFM protocols , 2019, American journal of hematology.

[5]  Jae Wook Lee,et al.  Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission , 2019, Blood research.

[6]  M. Hajjari,et al.  A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors , 2018, Journal of cellular physiology.

[7]  K. Zibara,et al.  Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches , 2018, Journal of cellular physiology.

[8]  H. Nakajima.  [Genetic abnormalities in AML]. , 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[9]  R. Vinhas,et al.  A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms , 2018, Haematologica.

[10]  M. Shahjahani,et al.  Sex chromosome changes in leukemia: cytogenetics and molecular aspects , 2018, Hematology.

[11]  K. Zibara,et al.  Genetics and Epigenetics of Glioblastoma: Therapeutic Challenges , 2018 .

[12]  D. Teachey,et al.  MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia , 2018, Haematologica.

[13]  H. Kantarjian,et al.  Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults , 2018, American journal of hematology.

[14]  S. Mercadal,et al.  Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia , 2018, Leukemia & lymphoma.

[15]  M. Breccia,et al.  Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update , 2017, Expert review of molecular diagnostics.

[16]  Qiaojia Huang,et al.  High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survival , 2017, Oncology letters.

[17]  C. Mullighan,et al.  TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia. , 2017, Cold Spring Harbor perspectives in medicine.

[18]  C. Mullighan,et al.  Genetic Basis of Acute Lymphoblastic Leukemia. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Shago.  Recurrent Cytogenetic Abnormalities in Acute Lymphoblastic Leukemia. , 2017, Methods in molecular biology.

[20]  J. Yang,et al.  Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia. , 2017, Methods in molecular biology.

[21]  B. Bostrom,et al.  Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone , 2016, Journal of pediatric hematology/oncology.

[22]  Zhijie Kang,et al.  The Philadelphia chromosome in leukemogenesis , 2016, Chinese journal of cancer.

[23]  I. Aldoss,et al.  Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  A. Biondi,et al.  Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia , 2015, Haematologica.

[25]  M. Shahjahani,et al.  Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy , 2015, Oncology reviews.

[26]  S. Howard,et al.  Outcomes in Patients With Mixed Phenotype Acute Leukemia in Morocco , 2014, Journal of pediatric hematology/oncology.

[27]  J. Schouten,et al.  Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics , 2014, Hematology.

[28]  M. D. Den Boer,et al.  IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. , 2014, Blood.

[29]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[30]  T. Naoe,et al.  High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  T. Naoe,et al.  Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: Major challenges in current practice , 2006, Leukemia & lymphoma.

[32]  S. Shukla,et al.  Atypical D-FISH patterns of BCR/ABL gene rearrangements in 169 chronic myeloid leukemia patients. , 2006, Journal of the Association of Genetic Technologists.

[33]  N. Heerema,et al.  Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group , 2004, Leukemia.

[34]  C. Pui,et al.  Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome , 2004, Leukemia.

[35]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[36]  J. Shuster,et al.  Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1991, Blood.